A Feasibility Study to Collect Data in Patients With Haemophilia

Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment

NCT02396862 ·Status: COMPLETED

Evaluation of a Standardized Protocol for Thrombin Generation Assay

NCT03313531 ·Status: COMPLETED

Thrombin Generation Numerical Models Validation in Haemophilic Case

NCT02300519 ·Status: COMPLETED

Genetic Susceptibility to Factor VIII Inhibitors

NCT00344435 ·Status: COMPLETED

Data Registry in Chinese Hemophilia A and B Patients

NCT07101224 ·Status: COMPLETED

ATHN 7: Hemophilia Natural History Study

NCT03619863 ·Status: COMPLETED

A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)

NCT03741881 ·Status: COMPLETED

Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

NCT00178607 ·Status: COMPLETED

TFPI Levels in Haemophilia A and B Patients

NCT04570696 ·Status: UNKNOWN

A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment

NCT02476942 ·Status: COMPLETED

Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease

NCT02061033 ·Status: UNKNOWN

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917 ·Status: COMPLETED ·Phase: PHASE3

First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia Patients

NCT01191372 ·Status: TERMINATED ·Phase: PHASE1

Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders

NCT02324517 ·Status: UNKNOWN

Clinical and Health-related Outcome of rFVIIIFc Prophylaxis

NCT04583930 ·Status: UNKNOWN

Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B

NCT03276130 ·Status: COMPLETED

Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A

NCT01692925 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A

NCT01205724 ·Status: COMPLETED ·Phase: PHASE1

Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function

NCT02225483 ·Status: COMPLETED

ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

NCT02078427 ·Status: COMPLETED

Long-term Anticoagulation in a Patient With Severe Hemophilia A

NCT07314983 ·Status: RECRUITING

Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and B

NCT03287999 ·Status: UNKNOWN

A Prospective Study Evaluating Seroprevalence and Seroconversion of Antibodies Against Adeno-associated Virus (AAV)

NCT05580692 ·Status: TERMINATED ·Phase: NA

Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A

NCT00782470 ·Status: COMPLETED

Personalized Prediction of Tolerance and Immunogenicity in Hemophilia

NCT01626105 ·Status: UNKNOWN